Advanced method for determination of omeprazole in plasma by HPLC

Archives of Pharmacal Research

Volumn 22, Issue 1, 1999, Pages 86-88

  Kang, Won Ku ^a   Kim, Dong Sup ^b   Kwon, Kwang Il ^a  

^a Chungnam National University   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

Author keywords

HPLC; Human volunteers; Omeprazole; Plasma

Indexed keywords

ANTIULCER AGENT; OMEPRAZOLE;

AREA UNDER THE CURVE; ARTICLE; BLOOD; CALIBRATION; CLINICAL TRIAL; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTI-ULCER AGENTS; AREA UNDER CURVE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HALF-LIFE; HUMANS; OMEPRAZOLE; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0033073896     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976443     Document Type: Article

References (6)

1. Dipiro, J. T., Blouin, R. A., Pruemer, J. M. and Spruill, W. J., Concepts in Clinical Pharmacokinetics. A Self-instructional Course. 11-35, ASHP, Wisconsin, 1988.
2. Macek, J., Ptacek, P. and Klima, J., Determination of omeprazole in human plasma by HPLC. J. Chromatogr., 689, 239-243 (1997).
3. Amanrea, M. A. and Narang, P. K., Improved procedure for quantitation of omeprazole and metabolites using reversed-phase HPLC. J. Chromatogr., 426, 216-222 (1988).
4. Shim, S. H., Bok, S. J. and Kwon, K. I., Determination of omeprazole in rat plasma by HPLC with column switching. Arch. Pharm. Research, 17, 458-461 (1994).
5. Berglindh, T., Hansen, D. and Bergqvist, E., Emerging strategies in ulcer therapy: pumps and receptors. Scand. J. Gastroenterol. Suppl., 108, 7-14 (1985).
6. +)-ATPase in vivo by omeprazole. Biochem. Biophys. Res. Commun., 126, 78 (1985).